Keyphrases
NeuroAIDS
100%
Connexin Hemichannels
100%
Pannexin Channels
85%
Channel Opening
42%
HIV Infection
28%
Neuroinflammation
28%
Host Factors
28%
Transmigration
28%
Patient Samples
14%
Pannexin 1 (Panx1)
14%
Inflammation
14%
Encoded Protein
14%
Physiological Condition
14%
Surface Aggregation
14%
Monocyte Maturation
14%
Infected Leukocytes
14%
HIV Entry
14%
Viral Replication
14%
Chemokines
14%
Closed State
14%
Neuroinflammatory Factors
14%
Multiple Steps
14%
Direct Regulation
14%
HIV Patients
14%
Receptor Trafficking
14%
Mimetic Peptide
14%
CNS Activity
14%
Receptor Function
14%
Immune Cells
14%
Therapeutic Target
14%
Leukocytes
14%
Neurological Injury
14%
Number of Patients
14%
Ethnic Groups
14%
Polymorphism
14%
People Living with HIV (PLHIV)
14%
C-C Chemokine Receptor Type 5 (CCR5)
14%
Leukocyte Migration
14%
BBB Integrity
14%
Potential Side Effects
14%
Adhesion Molecules
14%
HIV Life Cycle
14%
Surface Trafficking
14%
Channel Blocker
14%
Monocyte Differentiation
14%
Differential Expression
14%
Extracellular ATP (eATP)
14%
New Host
14%
Receptor Expression
14%
Leukocyte Differentiation
14%
HIV Receptors
14%
ATP Concentration
14%
Neurological Effects
14%
Viral Infection
14%
Purinergic Receptors
14%
CNS Disorders
14%
Immune System
14%
Biochemistry, Genetics and Molecular Biology
Pannexin
100%
Human Immunodeficiency Virus
100%
Adenosine Triphosphate
45%
Leukocyte
27%
Blood Brain Barrier
27%
Animal Model
9%
Maturation
9%
Peptide Mimetics
9%
Chemokine
9%
Purinergic Receptor
9%
Virus Replication
9%
CCR5
9%
Life Cycle
9%
Channel Blocker
9%
Immunocompetent Cell
9%
Immunity
9%
Cell Adhesion Proteins
9%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Blood Brain Barrier
33%
Leukocyte
33%
Host Factor
22%
Human Immunodeficiency Virus Infection
22%
Chemokine
11%
CCR5
11%
Immunocompetent Cell
11%
Viral Disease
11%
Viral Replication
11%
Maturation
11%
Life Cycle
11%
Peptides
11%
Immune System
11%
Cell Adhesion Proteins
11%